Richard Siller, Sebastian Greenhough, Santosh Mathapati, K. Si-Tayeb, G. Sullivan
{"title":"Future Challenges in the Generation of Hepatocyte-Like Cells From Human Pluripotent Stem Cells","authors":"Richard Siller, Sebastian Greenhough, Santosh Mathapati, K. Si-Tayeb, G. Sullivan","doi":"10.1007/s40139-017-0150-x","DOIUrl":"https://doi.org/10.1007/s40139-017-0150-x","url":null,"abstract":"","PeriodicalId":37014,"journal":{"name":"Current Pathobiology Reports","volume":"5 1","pages":"301-314"},"PeriodicalIF":0.0,"publicationDate":"2017-07-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/s40139-017-0150-x","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42006478","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"ER Stress and Autophagy in Obesity and Nonalcoholic Fatty Liver Disease","authors":"Nicholas R. L. Lind, Q. Qian, Ling Yang","doi":"10.1007/s40139-017-0145-7","DOIUrl":"https://doi.org/10.1007/s40139-017-0145-7","url":null,"abstract":"","PeriodicalId":37014,"journal":{"name":"Current Pathobiology Reports","volume":"5 1","pages":"289-299"},"PeriodicalIF":0.0,"publicationDate":"2017-06-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/s40139-017-0145-7","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49320688","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"An interspecies heart-to-heart: Using <i>Xenopus</i> to uncover the genetic basis of congenital heart disease.","authors":"Alexandra MacColl Garfinkel, Mustafa K Khokha","doi":"10.1007/s40139-017-0142-x","DOIUrl":"https://doi.org/10.1007/s40139-017-0142-x","url":null,"abstract":"<p><strong>Purpose of review: </strong>Given the enormous impact congenital heart disease has on child health, it is imperative that we improve our understanding of the disease mechanisms that underlie patient phenotypes and clinical outcomes. This review will outline the merits of using the frog model, <i>Xenopus,</i> as a tool to study human cardiac development and left-right patterning mechanisms associated with congenital heart disease.</p><p><strong>Recent findings: </strong>Patient-driven gene discovery continues to provide new insight into the mechanisms of congenital heart disease, and by extension, patient phenotypes and outcomes. By identifying gene variants in CHD patients, studies in <i>Xenopus</i> have elucidated the molecular mechanisms of how these candidate genes affect cardiac development, both cardiogenesis as well as left-right patterning, which can have a major impact on cardiac morphogenesis. <i>Xenopus</i> has also proved to be a useful screening tool for the biological relevance of identified patient-mutations, and ongoing investigations continue to illuminate disease mechanisms.</p><p><strong>Summary: </strong>Analyses in model organisms can help to elucidate the disease mechanisms underlying CHD patient phenotypes. Using <i>Xenopus</i> to disentangle the genotype-phenotype relationships of well-known and novel disease genes could enhance the ability of physicians to efficaciously treat patients and predict clinical outcomes, ultimately improving quality of life and survival rates of patients born with congenital heart disease.</p>","PeriodicalId":37014,"journal":{"name":"Current Pathobiology Reports","volume":"5 2","pages":"187-196"},"PeriodicalIF":0.0,"publicationDate":"2017-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/s40139-017-0142-x","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"35649150","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Autophagy and Ferroptosis - What's the Connection?","authors":"Rui Kang, Daolin Tang","doi":"10.1007/s40139-017-0139-5","DOIUrl":"10.1007/s40139-017-0139-5","url":null,"abstract":"<p><strong>Purpose of review: </strong>Autophagy is a conserved intracellular degradation system and plays a dual role in cell death, depending on context and phase. Ferroptosis is a new form of regulated cell death that mainly depends on iron accumulation and lipid peroxidation. In this review, we summarize the processes of autophagy and ferroptosis and discuss their crosstalk mechanisms at the molecular level.</p><p><strong>Recent findings: </strong>The original study shows that ferroptosis is morphologically, biochemically, and genetically distinct from autophagy and other types of cell death. However, recent studies demonstrate that activation of ferroptosis is indeed dependent on the induction of autophagy. Additionally, many ferroptosis regulators such as SLC7A11, GPX4, NRF2, p53, HSPB1, CISD1, FANCD2, and ACSL4 have been identified as potential regulators of autophagy.</p><p><strong>Summary: </strong>This review not only highlights the importance of autophagy as an emerging mechanism of ferroptosis, but also raises new insights regarding regulated cell death.</p>","PeriodicalId":37014,"journal":{"name":"Current Pathobiology Reports","volume":"5 2","pages":"153-159"},"PeriodicalIF":0.0,"publicationDate":"2017-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5640172/pdf/nihms869885.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"35456916","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Using zebrafish to model liver diseases-Where do we stand?","authors":"Duc-Hung Pham, Changwen Zhang, Chunyue Yin","doi":"10.1007/s40139-017-0141-y","DOIUrl":"https://doi.org/10.1007/s40139-017-0141-y","url":null,"abstract":"<p><strong>Purpose of review: </strong>The liver is the largest internal organ and performs both exocrine and endocrine function that is necessary for survival. Liver failure is among the leading causes of death and represents a major global health burden. Liver transplantation is the only effective treatment for end-stage liver diseases. Animal models advance our understanding of liver disease etiology and hold promise for the development of alternative therapies. Zebrafish has become an increasingly popular system for modeling liver diseases and complements the rodent models.</p><p><strong>Recent findings: </strong>The zebrafish liver contains main cell types that are found in mammalian liver and exhibits similar pathogenic responses to environmental insults and genetic mutations. Zebrafish have been used to model neonatal cholestasis, cholangiopathies, such as polycystic liver disease, alcoholic liver disease, and non-alcoholic fatty liver disease. It also provides a unique opportunity to study the plasticity of liver parenchymal cells during regeneration.</p><p><strong>Summary: </strong>In this review, we summarize the recent work of building zebrafish models of liver diseases. We highlight how these studies have brought new knowledge of disease mechanisms. We also discuss the advantages and challenges of using zebrafish to model liver diseases.</p>","PeriodicalId":37014,"journal":{"name":"Current Pathobiology Reports","volume":"5 2","pages":"207-221"},"PeriodicalIF":0.0,"publicationDate":"2017-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/s40139-017-0141-y","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"35567953","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Non-canonical activation of NRF2: New insights and its relevance to disease.","authors":"Matthew Dodson, Donna D Zhang","doi":"10.1007/s40139-017-0131-0","DOIUrl":"https://doi.org/10.1007/s40139-017-0131-0","url":null,"abstract":"<p><strong>Purpose of review: </strong>The goal of this review is to summarize the current knowledge in the field regarding the non-canonical activation of the NRF2 pathway. Specifically, we address what role p62 plays in mediating this pathway, which pathologies have been linked to the p62-dependent activation of NRF2, as well as what therapeutic strategies could be used to treat diseases associated with the non-canonical pathway.</p><p><strong>Recent findings: </strong>It has recently been shown that autophagic dysfunction leads to the aggregation or autophagosomal accumulation of p62, which sequesters KEAP1, resulting in prolonged activation of NRF2. The ability of p62 to outcompete NRF2 for KEAP1 binding depends on its abundance, or post-translational modifications to its key domains. Furthermore, the relevance of the p62-dependent activation of NRF2 in disease has been demonstrated in human hepatocellular carcinomas, as well as neurodegenerative diseases.</p><p><strong>Summary: </strong>These findings indicate that targeting p62, or the enzymes that modify it, could prove to be an advantageous strategy for treating diseases associated with autophagy dysregulation and prolonged activation of NRF2. Other therapeutic possibilities include restoring proper autophagic function, or directly inhibiting NRF2 or its targets, to restore redox and metabolic homeostasis. Future studies will help further clarify the mechanisms, regulation, and relevance of the non-canonical pathway in driving disease pathogenesis.</p>","PeriodicalId":37014,"journal":{"name":"Current Pathobiology Reports","volume":"5 2","pages":"171-176"},"PeriodicalIF":0.0,"publicationDate":"2017-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/s40139-017-0131-0","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"35649148","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Regulation of Exercise-Induced Autophagy in Skeletal Muscle.","authors":"Altea Rocchi, Congcong He","doi":"10.1007/s40139-017-0135-9","DOIUrl":"10.1007/s40139-017-0135-9","url":null,"abstract":"<p><strong>Purpose of review: </strong>Physical exercise is a highly effective method to prevent several pathogenic conditions, such as obesity, type 2 diabetes and cardiovascular diseases, largely due to metabolic adaptations induced by exercise in skeletal muscle. Yet how exercise induces the beneficial effects in muscle remains to be fully elucidated. Autophagy is a lysosomal degradation pathway that regulates nutrient recycling, energy production and organelle quality control. The autophagy pathway is upregulated in response to stress during exercise and muscle contraction, and may be an important mechanism mediating exercise-induced health benefits.</p><p><strong>Recent findings: </strong>A number of studies have indicated that physical exercise induces non-selective autophagy and selective mitophagy in skeletal muscle in animal models and humans. The AMPK-ULK1 and the FoxO3 signaling pathways play an essential role in the activation of the upstream autophagy machinery in skeletal muscle during exercise. The autophagy activity is required for health benefits of exercise, as in different autophagy-deficient mouse lines exercise-induced effects are abolished.</p><p><strong>Summary: </strong>This review aims to summarize and highlight the most recent findings on the role of autophagy in muscle maintenance, the molecular pathways that upregulate autophagy during exercise, and the potential functions of exercise-induced autophagy and mitophagy in skeletal muscle.</p>","PeriodicalId":37014,"journal":{"name":"Current Pathobiology Reports","volume":"5 2","pages":"177-186"},"PeriodicalIF":0.0,"publicationDate":"2017-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/s40139-017-0135-9","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"35629828","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}